Growth and division by most bacteria requires remodeling and cleavage of their cell 31 wall. A byproduct of this process is the generation of free peptidoglycan (PG) fragments known 32 as muropeptides. These muropeptides are recycled in many model organisms, where the 33 bacteria can harness their unique nature as a signal for cell wall damage. These molecules also 34 serve as important signals for hosts where binding to specific receptors reports on the presence 35 of intracellular bacteria. Despite this critical role for muropeptides, it has long been thought that 36 pathogenic mycobacteria such as Mycobacterium tuberculosis do not recycle their PG. Herein 37 we show that M. tuberculosis and Mycobacterium bovis BCG are both able to recycle 38 components of their PG. We demonstrate that MurNAc but not GlcNAc can be metabolised by 39 mycobacteria and that stem-peptide recycling proceeds independent of amino sugar recovery. 40
Introduction 46
For most bacteria maintenance of a peptidoglycan (PG) sacculus is an essential aspect 47 of life. PG is a heteropolymer comprised of glycan chains with a repeating disaccharide motif 48 of N-acetylglucosamine β1à4 N-acetylmuramic acid (GlcNAc-MurNAc) which are then cross-49 linked to one another via short peptides attached to the C-3 D-lactyl moiety of MurNAc. The 50 integrity of this macromolecule must be maintained under most growth conditions and its 51 rupture leads to lysis and cell death 1 . As a result of this essentiality, it is vital that cells are able 52 to withstand their own internal turgor pressure and still be able to cleave the cell wall to allow 53 for division, growth and the insertion of macromolecular structures such as secretion systems 1 . 54
Throughout this process, the activity of lytic enzymes or through the attack of host agents like 55 lysozyme, the sacculus is cleaved with the resulting generation of small PG metabolites known 56 as muropeptides 2 . 57
In Gram-positive bacteria muropeptides are typically released from the cell wall through 58 the action of lysozyme-like hydrolytic enzymes, whereas in Gram-negative bacteria, lytic 59 transglycosylases generate 1,6-anhydroMurNAc products 3,4 . These metabolites have been 60
shown to be important in many aspects of host-pathogen interactions. For example, tracheal 61 cytotoxin produced by Bordetella pertussis is the product of lytic transglycosylases 5 . Release 62 of a similar molecule has also been shown to be involved in tissue damage during Neisseria 63 gonorrhoeae infection and in the closure of the light-organ of the bobtail squid 6,7 . In many 64
In the present study we sought to determine if mycobacteria are capable of recycling 89 their PG and if so, what impact this has on the pathogenicity and immunogenicity of these 90 organisms. We for the first time reveal that these bacteria do indeed possess the biochemical 91 capacity to recycle PG elements and determined the molecular basis of MurNAc recovery. Our 92 data indicate that loss of a key recycling enzyme, LpqI, leads to increased antibiotic and 93 lysozyme resistance. Surprisingly, loss of this enzyme also leads to increased proliferation in 94 murine bone-marrow-derived macrophages suggesting that PG-recycling plays an important 95 role in maintaining balanced growth in the host. 96
Materials and methods

97
Bacterial strains and growth conditions: 98 M. bovis BCG (Pasteur) and related mutants were maintained on Middlebrook 7H10 99 agar or 7H9 broth supplemented with 10% OADC enrichment and 0.05% Tween 80. Where 100 appropriate kanamycin or hygromycin was added at 25 or 50 µg•mL -1 , respectively. M. 101 smegmatis mc 2 155 were maintained on Tryptic Soy Broth or Tryptic Soy Agar where 102 appropriate. For growth on defined carbon sources, strains were grown in Sauton's minimal 103 medium (4 g asparagine, 2 g citric acid, 0.5 g K2HPO4, 0.5 g MgSO4 * 7 H2O and 0.05 g ferric 104 ammonium citrate, 0.05% tyloxopol) containing either 5 mM of each sole-carbon unless stated 105 otherwise 15 . Escherichia coli strains were grown in lysogeny broth and supplemented with 106 kanamycin at 50 µg•mL -1 or hygromycin at 150 µg•mL -1 where appropriate. 107
Mutant generation 108
To generate the ∆lpqI strain we used specialized transduction according to established 109 protocols 16 . A recombinant lpqI knockout phage was designed to replace the chromosomal lpqI 110 gene using homologous flanking regions to lpqI with a the sacB gene and a hygromycin 111 resistance cassette in-between using the LL-Rv0237, LR-Rv0237, RR-Rv0237 and RL-Rv0237 112 primers (all primers are found in Table S2 ). The resulting phage was transduced into M. bovis 113 BCG and transductants were selected on 7H10-agar plates containing 75 µg•mL -1 hygromycin. 114
The mutant was verified by PCR and phenotypically with 4MU-GlcNAc where loss of lpqI was 115 expected to abolish turn-over of this fluorescent substrate. The complemented strain was 116 generated by incorporating the lpqI gene and 150 bp 5' to the start codon containing the 117 promoter sequence into the promoter-less integrative mycobacterial shuttle vector pMV306 118 using primers Rv0237CompF and Rv0237CompR to generate the resulting pMV306-lpqI 119 plasmid 17 . This was electroporated into M. bovis BCG ∆lpqI and transformants were selected 120 on 7H10 agar containing hygromycin and kanamycin. The complemented mutant was verified 121 phenotypically with 4MU-GlcNAc. A similar strain was constructed using the empty pMV306 122 vector. 123
Antimicrobial testing 124
Mid-exponential cultures of M. bovis BCG and derivative strains were diluted to the 125 indicated OD600 in fresh 7H9 media. 100 µL of this culture was added to a 96-well plate with 126 the addition of 1 µL of antibiotic/lysozyme to achieve the desired final concentration as 127 indicated. These were incubated for 7 days at 37 °C at which point 30 µL of 0.02% w/v resazurin 128 and 12.5 µL of 20% Tween 80 v/v was added to the culture. This was incubated over-night at 129 37 °C and the production of resorufin was determined by fluorescence (Ex. 530 nm, Em. 590 130 nm) using a BMG Polarstar plate reader. 131 98% phenol was added and vortexed for 1 min. This was heated for 1h at 70 °C, allowed to cool 138 and the insoluble material was collected by centrifugation at 5,000 rpm. The aqueous phase was 139 removed and 4 mL of methanol was added. This was vortexed and centrifuged again. Finally, 140 the pellet was washed 3 times with methanol and once with water before being frozen or used 141 for subsequent enzymatic treatment. 142
Large-scale purification of PG 143
Purification of PG from M. smegmatis was achieved following established protocols 19 . 144
Six-liters of M. smegmatis were grown to mid-exponential phase at which point they were 145 harvested by centrifugation, resuspended in a minimal volume of PBS and lysed by sonication. 146
The resulting lysate was brought to 4% SDS and boiled under reflux for 3 h. The insoluble 147 material was collected by centrifugation and washed with water until the SDS was completely 148 removed (at least 7 washes) to yield mycolyl-arabinogalactan-peptidoglycan (mAGP). The 149 mAGP was incubated for 4 days in 0.5% KOH in methanol at 37 °C before being washed three 150 times with methanol. The mycolic acids were extracted with 3 washes of diethyl ether. The 151 phosphodiester linking the AG-PG complex was cleaved using 0.2 M H2SO4 and the PG was 152 separated from the solubilized AG by centrifugation prior to neutralization with NaCO3 and 153 washed with water 3 times. The insoluble PG pellet was sequentially digested with α-amylase 154 (100 µg•mL -1 ), DNase (10 µg•mL -1 ) and RNase (5 µg•mL -1 ) for 8h before proteinase K (100 155 µg•mL -1 ) digestion overnight at 37 °C. The PG pellet was resuspended in a minimal volume of 156 1% SDS and boiled under reflux for 3 h before the SDS was removed by centrifugation and 157 washing with water (at least 7 times). The resulting material was lyophilized and stored at -20 158 °C until it was needed. 159
Digestion of cell wall material with mutanolysin was carried out overnight at 37 °C in 160 20 mM ammonium acetate buffer (pH 6.0) with continuous mixing. Following digestion 161 solubilised muropeptides were isolated using graphitized carbon solid-phase-extraction 162 cartridges as previously described 20 . Purified fractions were evaporated to dryness and the 163 concentration of reducing sugars in the pool of soluble muropeptides was assessed using the 3-164 methyl-2-benzothiazolinone hydrazone (MBTH) assay 21 . 165
Synthesis of 4MU-D-lactate 166
Instead of the 2-or 3-step protocols published for the synthesis of 4MU-D-lactate previously, 167
we used a simplified one step method 22,23 . 1.5 g of (s)-(-)-bromopropionic acid was added to 1 168 g of 4-methylumbelliferone stirring in 40 mL anhydrous dimethylformamide and 0.75 g 169
Cs2CO3. This was stirred at room temperature over-night and the product was extracted three 170 times with water/ethyl-acetate and the organic phase was dried over sodium sufate. The organic 171 phase was then filtered and evaporated to dryness. The product was subsequently purified using 172 silica chromatography and was dried as a crystalline white solid. 173
Turn-over of 4MU reporter compounds by M. bovis BCG 174
To test turn-over of 4MU-GlcNAc or 4MU-D-lactate by whole cells, 100 µL of a mid-175 exponential culture (OD600 = 0.6) was added to a sterile 96 well plate in Sauton's minimal media 176 supplemented with 0.05% Tween and 1% glycerol in addition to 1 mM 4MU-D-lactate or 4MU-177
GlcNAc. Similar controls lacking cells or the reporter compound were included as well. This 178 was incubated at 37 °C and mixed at 300 r.p.m. Each day the fluorescence of the sample was 179 read on a BMC PolarStar microplate reader (Ex. 355 nm; Em 460 nm) with a constant gain 180 setting. 181
Turn-over of M. bovis BCG PG in vitro 182
Cultures of M. bovis BCG wild-type, ∆lpqI, and ∆lpqI::lpqI were grown to an OD600 of 183 0.6 in the presence of 10 µCi 3 H meso-diaminopimelic acid (DAP), at which point they were 184 collected by centrifugation, washed 3 times with sterile media and diluted to 0.01 in fresh 185 culture flasks. Periodically a sample of 0.5 mL was taken, and the cells were collected by 186 centrifugation. The spent medium was mixed with 10 mL scinitilation fluid and counted using 187 a liquid scintillation counter. The cell pellet was re-suspended in 10% SDS, boiled for 20 min, 188 and centrifuged again. The cell-wall material was then resuspended in 1 mL scintillation fluid 189 and the material was counted in a liquid scintillation counter. The counts of the cell wall and 190 the media were added together to give total 3 H DAP in each culture and the data is presented as 191 a percentage of that total. During the course of the experiment the OD600 of the culture was 192 monitored daily. All measurements are from three biological replicates. Prior to crystallization, LpqI was concentrated to 20 mg•mL -1 in 25 mM Bis-Tris pH 210 7.5. LpqI crystals were grown by the sitting-drop vapour diffusion method by mixing an equal 211 volume of protein solution with 1.1 M sodium malonate, 0.1M HEPES, 0.5% v/v Jeffamine 212 ED-2001 (pH 7.0). Crystals were cryo-protected with a saturated solution of sodium malonate 213 and plunge frozen in liquid nitrogen. X-ray data was collected at the Diamond Light Source, 214
Oxford. Data were processed using XiaII and file manipulations were performed using the 215 CCP4 suite of programs. The structure was phased by molecular replacement using the 216 previously released, but unpublished M. smegmatis LpqI structure (PDB: 4YYF) using the 217 program PHASER. The structure was subsequently auto-built in PHENIX and the remaining 218 parts were built in COOT with further refinement using PHENIX and PDB-REDO. 219
Kinetic characterisation of Rv0237 220
Purified Rv0237 was evaluated for glycoside hydrolase activity using a variety of 221 substrates. As an initial screening assay, Rv0237 was incubated at 1 µM with either 4-222 methylumbeliferyl or p-nitrophenyl derivatives of a variety of sugars as listed in Figure 4a in 223
Bis-Tris pH 7.5, 100 mM NaCl at 37 °C. The release of p-nitrophenol was followed by change 224 in absorbance at 420 nm while production of 4-menthylumbelliferone was monitored by 225 fluorescence as above in a BMG Polarstar spectrophotometer. Kinetic characterisation of 226
Rv0237 was conducted using varying concentrations of 4MU-GlcNAc. The raw data were 227 compared to standards of 4-methylumbelliferone. All data were analysed using GraphPad Prism 228
229
To evaluate the ability of the enzyme to degrade fragments derived from PG, M. 230 smegmatis PG was digested with mutanolysin and soluble fragments were prepared and 231 quantified as above. Reactions including 1 µM Rv0237, 0.5 mM PG fragments in 25 mM 232 ammonium acetate buffer pH 6.5 were incubated for 18h at 37 °C. In parallel reactions were 233 carried out using pNP-GlcNAc in order to monitor enzyme activity visually. The reactions were 234 then evaluated by TLC (Silica 60 F254, Merck, Germany) using a mobile phase consisting of 1-235 butanol, methanol, ammonium hydroxide and water at a ratio of 5:6:4:1. TLCs were stained 236 with α-naphthol and developed by charring. 237
Infection of bone marrow-derived macrophages 238
BMDM were differentiated from bone marrow cells obtained from femurs and tibiae of 239 C57BL/6 mice cultured in the presence of L-cell conditioned medium, as described before 24 . 240
One million cells were infected with each M. bovis BCG strain at a multiplicity of infection 241 (moi) of 2 bacteria: 1 macrophage. Four hours after infection, cells were washed 4 times with 242 PBS (GIBCO) to remove extracellular bacteria. The adherent cells were cultured at 37°C in 1 243 mL of cDMEM in the presence or absence of 100 U/mL of IFN-γ for 96 hours. Four or 96 hours 244 post-infection, 0.1% saponin (Sigma-Aldrich) in PBS was added to the wells and the cells were 245 incubated at RT for 10 minutes to release intracellular bacteria. The number of viable bacteria 246 was determined by plating 10-fold serial dilutions of the saponin treated cell suspensions in 247
Middlebrook 7H11 supplemented with 10% OADC and 0.5% glycerol. Viable bacteria were 248 determined by CFU enumeration after 21-28 days of incubation at 37°C 24 . 249
Results
250
Peptidoglycan Recycling Genes in Mycobacteria 251
The genome of M tuberculosis encodes many lytic enzymes, including at least five 252
Resuscitation Promoting Factors (Rpfs) and greater than 10 peptidases and amidases in addition vitro 18, 28 . We hypothesized that a recycling system for these muropeptides is likely to also exist 266 in mycobacteria and analyzed the genomes of several mycobacteria for known PG-recycling 267 systems including the recently discovered systems of Pseudomonas putida and Tannerella 268 forsythia (Table S1, Figure 1 for which an apparently complete "classical" muropeptide recovery system exists, making it a 275 poor PG metabolism model for M. tuberculosis (Table S1 ). The M. tuberculosis, M. leprae, C. 276 glutamicum and M. bovis BCG genomes do, however, appear to encode orthologs of NagA and 277
NagZ. These enzymes are predicted to be an N-acetylglucosamine-6-phosphate N-deacetylase 278 and a GH3-family β-N-acetylglucosaminidase respectively 31,32 . NagZ in particular is typically 279 associated with PG recycling, whilst NagA is typically associated with the assimilation of 280
GlcNAc regardless of the source. 281
Utilisation of peptidoglycan components by mycobacteria 282
Prior research has shown that most mycobacteria are unable to use GlcNAc as a sole 283 carbon source, with M. smegmatis being one of the notable exceptions 33 . Furthermore, amino 284 acids including L-Ala, L-Glu, and L-Asp have previously been shown to serve as nitrogen 285 sources for M. tuberculosis H37Rv 34 . To our knowledge, recycling of GlcNAc or MurNAc has 286 not been reported, nor has recycling been evaluated for soluble PG fragments. To evaluate this, 287 M. bovis BCG was cultured in minimal media supplemented with glycerol (1% v/v) or MurNAc 288 (0.2% w/v) in Sauton's minimal media with constant aeration (Figure 2a ). To confirm that this 289
was not a phenotype specific to M. bovis BCG we also evaluated the ability of M. tuberculosis 290
H37Rv to grow on the same carbon sources with identical results (Figure 2b ) Intriguingly this 291 growth was heavily dependent on the availability of oxygen. In contrast, growth on glycerol 292 was unaffected by this change (Figure 2c ). To further evaluate the potential for simple re-use 293 rather than metabolism of GlcNAc we tested the ability of M. bovis BCG to incorporate 14 C 294
GlcNAc into whole cells. Under different growth conditions (rich medium, carbon-poor 295 medium, aerated cultures, static cultures) we were unable to detect significant amounts of 296 GlcNAc being taken up by M. bovis BCG. In all cases the c.p.m. of the label in whole-cells was 297 less than that of unlabeled controls. 298
Mechanism of MurNAc metabolism 299
The ability of M. tuberculosis and M. bovis BCG to grow on MurNAc was surprising 300 and so we evaluated the biochemical processing steps associated with MurNAc utilization. 301
MurNAc is a combination of GlcNAc and D-lactate joined by an ether linkage. This suggests 302 that the bacterium is likely either using the GlcNAc moiety for glycolysis, or shunting the lactate 303 derived from MurNAc into the TCA cycle. We tested this inhibiting by glycolysis with 2-304 deoxyglucose (2DG) in cultures grown using MurNAc, glucose and glycerol as sole carbon 305 sources ( Figure S1 ). These data suggested that the pathway of MurNAc utilization did not 306 require glycolysis and indicated that lactate instead was likely serving as a carbon source. 307
Consistent with this, when used as a sole carbon source, growth on L-lactate and MurNAc was 308 O2 dependent while D-lactate was better utilized under static, 5% CO2 culture conditions, where 309
MurNAc could not be used as a carbon source (Figure 2c) . 310
These data allow us to hypothesize a mechanism by which M. bovis BCG metabolises 311 MurNAc. Given that metabolism of L-lactate and MurNAc are O2-dependent, we anticipate that 312 use of MurNAc follows cleavage of the D-lactate from MurNAc via an inverting mechanism to 313 produce L-lactate and GlcNAc. In this case, the O2-dependency on MurNAc metabolism is 314 likely the result of an O2-depenedent lactate monooxygenase. Consistent with this, two O2-315 dependent L-lactate monooxygenases have been identified in M. tuberculosis (Rv0694, 316
Rv1872c) 35 . Generation of free lactate by the bacterium would require the activity of a lactyl-317 etherase enzyme. To test for the presence of this activity we synthesized a 4MU-D-lactate 318 derivative to serve as a reporter-analog of MurNAc ( Figure S2 ). Consistent with the presence 319 of a lactyl etherase, cultures of M. bovis BCG were able to release 4MU from this compound 320 during the course of growth (Figure 2d ). 321
Uptake of PG metabolites by mycobacteria 322
While our data strongly support metabolism of MurNAc by M. bovis BCG, confirmation 323 of PG-recycling requires demonstration of the uptake of muropeptides by the bacterium. To 324 investigate this, we generated radio-labelled muropeptides and tested them in whole-cell uptake 325 assays to determine if mycobacteria are competent for recycling this more complex substrate. 326
Muropeptides had to be generated in M. smegmatis due to the inability of M. bovis BCG to take-327 up 14 C GlcNAc under the conditions we tested. As shown in Figure 3a , M. bovis BCG was able 328
to incorporate approximately 4% of the muropeptide-associated 14 C radio-label added to the 329 culture. We next sought to determine if components of the stem-peptide were also recycled. 330
The above experiments were repeated using 3 H-DAP-labelled muropeptides. This material was 331 also incorporated into whole cells at a rate of approximately 7% of the added label (Figure 3a) . 332
We next evaluated the turn-over of muropeptides in whole cells using 3 H-DAP due to the 333 inability of M. bovis BCG to incorporate 14 C GlcNAc into its cell wall. As shown in Figure 3c , 334 M. bovis BCG very slowly releases DAP to the culture media in vitro. Consistent with a PG-335 recycling system we also found that soluble PG could serve as a sole carbon source for M. bovis 336 BCG under aerated conditions (Figure 3d ). Together, these results indicate that pathogenic 337 mycobacteria possess the biochemical capacity to recycle components of their cell wall. 338
Biochemical and structural characterisation of LpqI 339
In previously characterized PG-recycling systems free amino sugars are by a glycoside with GlcNAc-containing substrates. Critically, this sugar is only found in the backbone of PG 367 and a small amount in the linker unit (MurNAc-6-P-Rha-GlcNAc-galactan) between PG and 368 arabinogalactan. We then evaluated the Michaelis-Menten kinetics of LpqI using 4MU-GlcNAc 369 as a substrate with a similar kcat (2.8 x 10 -2 ± 0.04 x 10 -2 •s -1 ) and Km (106 ± 5 µM) as observed 370 for other NagZ enzymes using this substrate (Figure 4b ) 39 . In a similar assay we were also able 371 to show that LpqI releases GlcNAc from soluble PG fragments (Figure 4c ). While hydrolytic 372 activity has been reported for most NagZ-type enzymes, a recent report suggested that β-N-373 acetylglucosaminidases from the GH3 family are in fact phosphorylases 38 . Another GH3 β-N-374 acetylglucosaminidase was recently reported to lack this activity, suggesting that it may not be 375 a general property of the family 43 . We tested the activity of the enzyme under the same 376 conditions as reported previously for Nag3 from Celulomonas fimi and found that there was no 377 detectable difference with our observed hydrolytic activity. The product of the reaction also co-378 migrated with GlcNAc on TLCs and not GlcNAc-1-P ( Figure S3 ). 379
To further validate its role in PG-recycling we solved the 1.96 Å crystal structure of 380 LpqI (PDB code: 6GFV; Figure 4d , S4, Table S3 ). LpqI consists of a single TIM-barrel domain 381 similar to cytoplasmic Gram-negative orthologs but lacks the C-terminal domain associated 382 with extracellular NagZ enzymes from some Gram-positive bacteria ( Figure S4 ). Alignment of 383
LpqI with the NagZ/GlcNAc/1,6-anhydroMurNAc complex from Pseudomonas aeruginosa 384 (NagZPa; PDB:5G3R) or NagZ from Bacillus subtilis (PDB:4GYJ) resulted in a root-mean-385 square deviation of 0.96 Å and 1.01 Å respectively ( Figure S4 ). Superposition of the post-386 cleavage NagZPa complex with LpqI indicates that the appropriate coordinating residues for 387 substrate recognition are intact in LpqI, supporting its role in PG-recycling (Figure 4d) . 388
Characterisation of a ∆lpqI mutant 389
To evaluate the role of LpqI in muropeptide recovery, we constructed a mutant strain of 390 M. bovis BCG lacking lpqI using specialized transduction and confirmed the mutant by PCR 16 . 391
A whole cell β-N-acetylglucosaminidase assay clearly shows that M. bovis BCG ∆lpqi is devoid 392 of β-N-acetylglucosaminidase activity as the amount of 4MU released is not significantly 393 different from the spontaneous release in sterile media (Figure 3b ). This deficiency is 394 complemented by replacement of the lpqI gene at a distal chromosomal location under the 395 control of its native promoter (∆lpqi::lpqI) and is not complemented by the empty vector 396 (∆lpqi::EV) (Figure 3b ). Growth of ∆lpqi in vitro is unaltered as compared to the wild-type 397 (Figure 3c ). 398
The order in which muropeptides are recycled, and the chemical structure of the 399 recycled material is critical for the immune sensing of the bacterium. To determine the order of 400 PG-recycling steps, we first determined the impact of the loss of lpqI on the recycling of cell 401 wall material. We repeated the radio-label incorporation assay described above with the mutant 402 and observed that the ∆lpqI was able to incorporate 3 H stem-peptides from soluble PG as 403 efficiently as the wild-type (Figure 3b ). Consistent with these observations, when we followed 404 release of pre-labelled cells for release of 3 H DAP into the culture media, we observed no 405 significant differences between the wild-type and the ∆lpqI strain (Figure 3c ). This experiment 406 reported on the recycling of stem-peptides, however it did not indicate if the mutant strain was 407 still recycling MurNAc. To test this directly we evaluated the ability of the ∆lpqI strain to grow 408 on MurNAc, glycerol and PG. The ∆lpqI strain was not deficient for growth on MurNAc or 409 glycerol, however unlike the wild-type strain it was unable to grow on PG as a sole-carbon 410 source (Figure 3d) . Similarly, the ∆lpqI strain incorporated significantly fewer 14 C-GlcNAc-411 labelled muropeptides (Figure 3a ). Together these data indicate that in vitro lpqI is required for 412 amino-sugar recycling, but is not necessary for stem-peptide recycling or release. 413
Given that NagZ-like proteins have been found to play a role in β-lactam sensitivity in 414 other bacteria we sought to determine the antibiotic sensitivity of the ∆lpqI strain. In contrast 415 to inhibition of P. aeruginosa NagZ, deletion of lpqI resulted in a significant increase in survival 416 for lysozyme and all cell-wall active antibiotics tested (Figure 5a-d) 44 . A smaller impact on 417 survival in the presence of the protein synthesis inhibitor chloramphenicol was observed 418 (Figure 5e ). This increase in resistance is not likely due to a change in cell-wall permeability as 419 determined by ethidium bromide uptake (Figure 5f ). 420
In vitro characterization of a ∆lpqI mutant 421
We next sought to determine the impact of the loss of lpqI on host responses to infection. 422
Bone-marrow derived macrophages were infected with M. bovis BCG WT, ∆lpqi, ∆lpqi::lpqi 423 and ∆lpqi::EV at an MOI of 2 and evaluated for total colony forming units (CFU) at 4h and 4 424 days post-infection. While no significant differences were observed at 4 h post-infection, a log-425 increase in CFUs was observed in the ∆lpqI and ∆lpqI::empty vector strains as compared to the 426 wild-type or complemented mutant ( Figure 6 ). This striking result indicated that although 427 bacteria uptake by macrophages is independent of LpqI, growth of M. bovis BCG in the 428 macrophage is controlled in a lpqI-dependent manner. 429
As a result of the apparent increase in fitness of a ∆lpqI strain under the conditions tested 430 we analyzed all available M. tuberculosis genomic sequences using BLAST for mutations in 431 the lpqI coding or promoter regions. We were unable to identify any deletions/mutations in the 432 promoter region for this protein and all identified mutations in the coding sequence were in 433 positions unlikely to be involved in catalysis or binding or were conservative mutations and 434 thus unlikely to impact function. 435
Discussion
436
In an attempt to develop diagnostic media for the identification of mycobacteria, several 437 groups in the 1960s observed that M. tuberculosis and most other mycobacteria could not 438 metabolise GlcNAc as a sole carbon-source 33,34 . This, along with the absence of known PG 439 recycling-associated genes lead to the assumption that PG recycling is absent in pathogenic 440 mycobacteria. Our sole-carbon source assays indicate that while the bacteria are unable to 441 metabolise GlcNAc, surprisingly they can metabolise MurNAc (Figure 2) . This is despite the 442 fact that they lack an ortholog of the only known lactyl-etherase, MurQ which cleaves an 443 otherwise stable lactyl-ether in the cytoplasm of most model organisms (Figure 1 ). Our data 444 indicate that rather than using the GlcNAc portion of the sugar, the bacteria are cleaving the 445 lactyl-ether and capable of metabolising the liberated lactate. During our study we found that 446 M. bovis BCG was only able to grow on MurNAc under aerated conditions. This was also found 447 to be the case for L-but not D-lactate which served as a much better carbon source under O2 448 limiting conditions. As MurNAc is a combination of D-lactate and GlcNAc, we can predict that 449 the lactyl etherase acting on MurNAc is likely proceeding via an inverting mechanism. The 450 presence of a specific lactyl-etherase is supported by the turnover of a 4MU-D-lactate reporter 451 compound by M. bovis BCG. The O2 dependence of this growth is intriguing as N-glycolylation 452 is also an O2-dependent activity, suggesting significant alterations to PG metabolism in hypoxic 453 vs. aerobically growing mycobacteria 45 . Consistent with this observation, Rv0237 has a 2-fold 454 upregulation during re-aeration after re-activation from non-replicating persistence in the 455 Wayne hypoxia model 46 . 456 Autolytic enzymes that cleave the glycan backbone of PG such as glucosaminidases, 457 lytic transglycosylases and lysozymes generally produce disaccharides. As such, free MurNAc 458 is unlikely to be generated by the known complement of autolytic enzymes in TB. We therefore 459 sought to identify the biochemical source of free amino-sugars which would feed a PG-460 recycling system. To do this, we biochemically and structurally characterised the predicted 461 mycobacterial NagZ ortholog, LpqI demonstrating that it is an authentic β-N-462 acetylglucosaminidase which is active against PG fragments. Consistent with a role in PG-463 recycling, M. bovis BCG ∆lpqI is unable to grow on soluble PG as a sole carbon source, while 464 recycling of the stem-peptide is unaltered in this mutant (Figure 3 ). Furthermore, uptake of 465 radio-labelled stem peptides was unchanged in the ∆lpqI mutant whereas 14 C GlcNAc-466 muropeptides show a significant decrease in incorporation (Figure 3 ). Together, these data 467 demonstrate that M. bovis BCG and M. tuberculosis remove the stem-peptide from PG-468 fragments prior to disaccharide cleavage and lactyl-ether removal (Figure 7) . The processing 469 of GlcNAc-MurNAc by LpqI prior to lactyl-ether cleavage is also supported by our LpqI crystal 470 structure in which the lactate-binding residue R67 from the P. aeruginosa structure is conserved 471
The fate of GlcNAc in this pathway remains unclear, although our data and prior 473 observations suggest that the bacteria do not re-use this sugar. This is surprising given the 474 conservation of the nagA (Rv3332) gene in mycobacteria, however it is possible that an 475 alternative pathway exists which involves intermediates not generated under the conditions we 476 have tested. This is hinted at with our 14 C-labelled muropeptides where incorporation of the 477 labelled-GlcNAc is not expected given the lack of GlcNAc utilisation by the cells. It is likely 478 that at least some portion of the labelled material is labelled at MurNAc rather than GlcNAc 479 and that the sugar moiety is in fact used as some alternative reaction product upon cleavage of 480 the lactyl-ether. Bacterial etherases comprise a diverse number of mechanisms and potential 481 reaction products and so a product other than free GlcNAc is entirely possible 47 . We are 482 currently trying to identify and characterise this enzyme. 483
The recycling of bacterial PG has immense implications for the host-pathogen 484 relationship. PG has been shown to be a pathogen-associated molecular pattern and is detected 485 by many different specialised host receptors 8, 48 . Of most relevance to M. tuberculosis is the 486 NOD2 receptor which senses intracellular muramyl-dipeptide (MurNAc-L-Ala-D-isoGlu) as a 487 minimal motif 8 . The immunogenicity of Freund's complete adjuvant, for example, is driven by 488 the presence of mycobacterial PG and its N-glycolyl modification 49 . Despite this, Hansen and 489 colleagues observed that the detection of M. tuberculosis by the immune system via Nod2 is 490 weaker than expected, with equal preparations of dead bacteria having substantially more 491 NOD2-stimulatory activity than wild-type bacteria 50 . The authors of that study speculated that 492 this was either due to active repression of the immune system or a reduction in the amount of 493 free NOD2-stimulatory effectors in live bacteria. 494
In our work, we have shown that mycobacteria recycle their PG by first cleaving the 495 stem peptide from the glycan backbone, and subsequently recycle the MurNAc portion of the 496 glycan, removing the D-lactate. This step-wise activity, starting with stem peptide removal, 497 would dramatically reduce the release of NOD2-stimulatory molecules, especially given that 498 this activity is happening beneath the mycomembrane, where diffusion of muropeptides is 499 expected to be highly restricted. Heat-killing of these bacteria would allow host-derived 500 lysozymes to release muropeptides and for those muropeptides to be able to diffuse and 501 stimulate NOD2 and other receptors. In line with this, our preliminary analysis suggest that 502 absence of LpqI does not alter the production of cytokines by infected bone-marrow-derived 503 macrophages (data not shown). 504
Deletion of the lpqI gene from M. bovis BCG yielded several surprising observations. 505
Impaired PG recycling has resulted in a strain that is more resistant to both lysozyme and several 506 antibiotics while not affecting growth in vitro. We are currently investigating the mechanistic 507 basis for this, though it is not likely due to a change in permeability of the cell wall ( Figure 5) . 508
In other bacteria cell wall damage can trigger various stress responses, and so it is likely that a 509 build-up of GlcNAc-MurNAc disaccharides may trigger a stress-like response in 510 mycobacteria 51 . Consistent with this lpqI is encoded adjacent to a universal stress response 511 protein in several mycobacteria ( Figure S5) . 512
Loss of this gene has also resulted in a substantial increase in growth in bone-marrow 513 derived macrophages ( Figure 6 ) suggesting that cell-wall turnover may act as a growth-rate 514 modulator in vivo. Despite these apparent fitness advantages, the lpqI gene appears to be intact 515 in virtually all mycobacteria for which sequence data is publicly available, and observed 516 mutations are unlikely to impact catalysis ( Figure S5 ). This suggests that there is a fitness cost 517 to the inactivation of this gene and warrants further investigation, perhaps in whole organismal 518 models. One possibility is that under stress-conditions mycobacteria may be able to scavenge 519 PG fragments from nearby dead cells allowing a small population to re-grow following mass 520 lysis. This is consistent with the observation that PG can lead to resuscitation of dormant 521 mycobacteria 52 . Alternatively, ∆lpqI-driven excessive growth in the macrophage may prevent 522 the development of a stable, long-term infection. PG recycling has also been shown to be critical 523
for Gram-positive bacteria in stationary phase, though our data do not support this requirement 524 for M. bovis BCG, it is possible that it is more important in the host 53 . 525
In conclusion, we have identified for the first time a PG recovery pathway in pathogenic 526 mycobacteria. We have shown that this occurs in a step-wise fashion by removing stem-peptide 527 from PG and subsequently cleaving the PG-disaccharide and finally releasing the D-lactate from 528 free MurNAc, most likely via an inverting mechanism. Finally, recycling of PG by these 529 bacteria is important for lysozyme and antibiotic tolerance, while deletion of this system results 530 in a significant growth advantage for these bacteria in macrophages. 531
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MurNAc, GlcNAc, L-lactate, D-lactate, and glycerol was evaluated in aerated or static 5% CO2 578 cultures using a resazurin assay (n = 3). d) Mid-exponential M. bovis BCG was grown in 579 minimal media with 5 mM glycerol including 1 mM 4MU-D-lactate with constant agitation. At 580 the indicated times the 4MU fluorescence of the samples was determined (n = 3). were incubated with 30,000 CPM of 14 C GlcNAc-labelled muropeptides or 100, 000 CPM of 586 3 H DAP-labelled muropeptides for 10 days after which the cell wall material was isolated and 587 subjected to liquid scintillation counting (n = 2). b) The same strains were incubated with 1 588 mM 4MU-GlcNAc in minimal media. After 3 days the fluorescence of the cultures were 589 measured (n = 3). c) M. bovis BCG WT and ∆lpqI were simultaneously evaluated for release of 590 cell wall peptides and growth (n = 3). d) The same strains were evaluated for their growth using 591 glycerol, MurNAc and PG as sole carbon sources using a resazurin assay (n = 3; *** = p < 592 0.001; ** = p < 0.005). 593 594 Figure 4 . LpqI is an authentic NagZ-type enzyme. a) Reactions including 1 µM LpqI and 596 the indicated chromogenic substrates at 1 mM were incubated at 37 °C and release of pNP or 597 4MU was followed by absorbance or fluorescence respectively. b) LpqI was incubated with 598 increasing concentrations of 4MU-GlcNAc. The rate of 4MU release was plotted and the curve 599
fit with the Michaelis-Menton equation using GraphPad Prism 7.0. (n = 3) c) LpqI is able to 600 release GlcNAc from soluble muropeptides derived from M. smegmatis mc 2 155 PG. d) The 601
active site of LpqI is highly conserved as evidenced by the nearly identical positioning of key 602 binding residues observed in the GlcNAc, 1,6-anhydroMurNAc complex with NagZPa (PDB: 603 5G3R) with an overall RMSD of 1.01 Å. 604 605 620 Figure 6 . Loss of lpqI leads to increased growth in BMDMs. Freshly prepared BMDs were 621
infected with the indicated strains at a multiplicity of infection of 2 and incubated for at 37 °C. 622
At the indicated times the macrophages were lysed with saponin and CFUs were measured on 623 7H11 agar after 3 weeks incubation (n ≥ 4; **** = p < 0.0001). 624 625
